Complement and Fc-receptors in regulation of the antibody response.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Immunology Letters

• Publication date

  1996-12-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0165-2478(96)02672-7PMID 9052877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody response to a T-dependent antigen requires B cell expression of complement receptors

  1996cited by this paper
• Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

  1996cited by this paper
• Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.

  1996cited by this paper
• Augmented humoral and anaphylactic responses in FcγRII-deficient mice

  1996cited by this paper
• Regulation of the B cell response to T-dependent antigens by classical pathway complement.

  1996cited by this paper
• Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

  1996cited by this paper
• Tyrosine phosphatases and the antibody response.

  1995cited by this paper
• No role of interleukin‐4 in CD23/IgE‐mediated enhancement of the murine antibody response in vivo

  1995cited by this paper
• Complement activation by cross-linked B cell-membrane IgM.

  1995cited by this paper
• The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.

  1995cited by this paper
• Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice

  1995cited by this paper
• Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction.

  1995cited by this paper
• Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.

  1995cited by this paper
• CD23/IgE-mediated regulation of the specific antibody response in vivo.

  1994cited by this paper
• The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice.

  1994cited by this paper
• Cloning of cDNAs for New Subtypes of Murine Low-Affinity Fc Receptor for IgE (FcεRII/CD23)

  1994cited by this paper
• Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates.

  1994cited by this paper
• Cloning of cDNAs for new subtypes of murine low-affinity Fc receptor for IgE (Fc epsilon RII/CD23).

  1994cited by this paper
• Negative feedback regulation of IgE synthesis by murine CD23

  1994cited by this paper
• Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells.

  1993cited by this paper
• Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23.

  1993cited by this paper
• The oligomeric nature of the murine Fc epsilon RII/CD23. Implications for function.

  1993cited by this paper
• Functional consequences of engagement of the T cell receptor by low affinity ligands.

  1993cited by this paper
• In vivo enhancement of the specific antibody response via the low‐affinity receptor for IgE

  1993cited by this paper
• CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.

  1992cited by this paper
• Spontaneous and ligand‐induced endocytosis of CD23 (Fcϵ receptor II) from the surface of B lymphocytes generates a 16‐kDa intracellular fragment

  1992cited by this paper
• The Low‐Affinity Receptor for IgE

  1992cited by this paper
• Suppression of the immune response by a soluble complement receptor of B lymphocytes.

  1991cited by this paper
• Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo.

  1991cited by this paper
• Inhibition of immunological memory and T‐independent humoral responses by monoclonal antibodies specific for murine complement receptors

  1991cited by this paper
• Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.

  1990cited by this paper
• Evidence of IgG‐mediated enhancement of the antibody response in vivo without complement activation via the classical pathway

  1990cited by this paper
• In vivo inhibition of the antibody response by a complement receptor- specific monoclonal antibody

  1990cited by this paper
• A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.

  1990cited by this paper
• Fc‐Dependent IgG‐Mediated Suppression of the Antibody Response: Fact or Artefact?

  1990cited by this paper
• IgE‐dependent antigen focusing by human B lymphocytes is mediated by the low‐affinity receptor for IgE

  1990cited by this paper
• Substitution of asparagine324 with aspartic acid in the fc portion of mouse antibodies reduces their capacity for clq binding

  1989cited by this paper
• Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing.

  1989cited by this paper
• Inhibition of IgG‐Mediated Immunosuppression by a Monoclonal Anti‐Fc Receptor Antibody

  1989cited by this paper
• Dual Immunoregulatory Effects of Monoclonal IgG‐Antibodies: Suppression and Enhancement of the Antibody Response

  1989cited by this paper
• Structure and function of human and murine receptors for IgG.

  1988cited by this paper
• Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs.

  1988cited by this paper
• Complement activation is not required for IgG‐mediated suppression of the antibody response

  1988cited by this paper
• Complement activation is required for IgM-mediated enhancement of the antibody response

  1988cited by this paper
• Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression.

  1988cited by this paper
• Two species of human Fcε receptor II (FcεRIICD23): Tissue-specific and IL-4-specific regulation of gene expression

  1988cited by this paper
• Complement activation by IgM: evidence for the importance of the third constant domain of the μ heavy chain

  1987cited by this paper
• The action of human C3 in soluble or cross‐linked form with resting and activated murine B lymphocytes

  1985cited by this paper
• Enhancement of IgG anti‐carrier responses by IgG2 anti‐hapten antibodies in mice

  1985cited by this paper
• Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.

  1985cited by this paper
• Specific IgM Enhances and IgG Inhibits the Induction of Immunological Memory in Mice

  1985cited by this paper
• Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens.

  1984cited by this paper
• Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype.

  1984cited by this paper
• Biological significance of carbohydrate chains on monoclonal antibodies.

  1983cited by this paper
• Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination

  1983cited by this paper
• Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal antihapten antibodies of various isotypes.

  1982cited by this paper
• Antigen-dependent IgM-mediated enhancement of the sheep erythrocyte response in mice. Evidence for induction of B cells with specificities other than that of the injected antibodies

  1982cited by this paper
• A new Fc receptor on mouse macrophages binding IgG3

  1981cited by this paper
• Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig.

  1981cited by this paper
• The enhancement of antibody response by IgM antibodies is dependent on antigen-specific T helper cells.

  1981cited by this paper
• Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus.

  1979cited by this paper
• Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen--antibody complexes.

  1979cited by this paper
• Suppression of Rh Isoimmunization: A Review

  1978cited by this paper
• Suppression of Rh isoimmunization. A review.

  1978cited by this paper
• Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.

  1975cited by this paper
• ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO

  1974cited by this paper
• Bound C3 as the second signal for B-cell activation

  1973cited by this paper
• Regulation of the immune response by IgM antibody: a paradoxical suppression of the in vitro primary immune response to sheep erythrocytes by passive IgM.

  1973cited by this paper
• Hypothesis. Bound C3 as the second signal for B-cell activation.

  1973cited by this paper
• REGULATION OF THE IMMUNE RESPONSE

  1971cited by this paper
• REGULATION OF THE IMMUNE RESPONSE

  1969cited by this paper
• COMPETITION OF 19S AND 7S ANTIGEN RECEPTORS IN THE REGULATION OF THE PRIMARY IMMUNE RESPONSE

  1968cited by this paper

• Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation.

  2023cites this paper
• Review of COVID-19 Antibody Therapies.

  2020cites this paper
• Review of COVID-19 Antibody Therapies.

  2020cites this paper
• Glycosylation-dependent antitumor therapeutic monoclonal antibodies.

  2019cites this paper
• Therapeutic Monoclonal Antibodies: Structure, Nomenclature and Current Approved Product Review

  2019cites this paper
• Protein crystallization: Eluding the bottleneck of X-ray crystallography

  2017cites this paper
• Chapter 23 – Preclinical Development of Monoclonal Antibodies

  2017cites this paper
• Structural Basis Of Membrane Protein Scaffolding And Signaling In Human Disease

  2017cites this paper
• Structure, Classification, and Naming of Therapeutic Monoclonal Antibodies

  2016cites this paper
• Preconception maternal exposure to Nippostrongylus brasiliensis transfers protection against Nb to her offspring

  2016cites this paper
• Molecular cloning of IgZ heavy chain isotype in Catla catla and comparative expression profile of IgZ and IgM following pathogenic infection

  2016cites this paper
• An apolipoprotein B100 mimotope prevents obesity in mice

  2015cites this paper
• Polymersomes mediated intracellular delivery of antibodies : implication in anticancer therapy

  2015cites this paper
• Roles of Igh Intronic Enhancer Eμ in Clonal Selection at the Pre-B to Immature B Cell Transition and in the Elimination of Autoreactive B Cells

  2014cites this paper
• An Fc Domain Protein–Small Molecule Conjugate as an Enhanced Immunomodulator

  2014cites this paper
• Highly covarying residues have a functional role in antibody constant domains

  2013cites this paper
• Preclinical Development of Monoclonal Antibodies

  2013cites this paper
• Continuing pursuit for ideal systemic anticancer radiotherapeutics

  2012cites this paper
• Cell separation: Terminology and practical considerations

  2012cites this paper
• Effect of Korean Mistletoe Lectin on Gene Expression Profile in Human T Lymphocytes: A Microarray Study

  2010cites this paper
• Structure-Guided Design of Antibodies.

  2010cites this paper
• Aptamer biosensor for lable-free detection of human immunoglobulin E based on surface plasmon resonance

  2009cites this paper
• Gene expression profiling of the effects of intravenous immunoglobulin in human whole blood.

  2006cites this paper
• Fc‐Dependent Monoclonal IgG1‐Mediated Suppression of Antibody Response

  2004cites this paper
• Fc receptor blockade and immune thrombocytopenic purpura.

  2000cites this paper
• Regulation of antibody responses via antibodies, complement, and Fc receptors.

  2000cites this paper
• Divergent roles for Fc receptors and complement in vivo.

  1998cites this paper
• Impaired antibody responses in H-2Ab mice.

  1998cites this paper
• Mice b Impaired Antibody Responses in H-2A

  1998cites this paper
• RIIb inhibits both B cell receptor-and CD 19-induced Ca 2 F mobilization in Fc γ R-transfected human B cells

  1998cites this paper
• Fc gammaRIIb inhibits both B cell receptor- and CD19-induced Ca2+ mobilization in Fc gammaR-transfected human B cells.

  1998cites this paper
• Highly Covarying Residues Have a Functional Role in Antibody Constant Domains

  year unknowncites this paper